Methylation of the GRAF promoter in patients with AML or MDS was examined by MS-PCR, in which methylated and unmethylated alleles are distinguished by conversion of all unmethylated, but not of the methylated, cytosine to uracil residues with bisulphite (Herman et al, 1996). Here, ARHGAP26 is linked to acute myeloid leukemia.